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Abstract: BACKGROUND: Psoriatic arthritis is an inflammatory arthritis associated with psoriasis. Its prevalence in patients with
psoriasis varies from 7 to 42% but its exact prevalence is unknown. 
OBJECTIVES: Considering the lack of national data related to its diagnosis in patients with psoriasis, this study aims to descri-
be the clinical, laboratorial and radiological manifestations of psoriatic arthritis in these patients. 
METHODS: We evaluated 133 patients with psoriasis, treated as outpatients. These patients were asked to fill in the forms with
data about the disease and were submitted to a clinical evaluation by a dermatologist and a rheumatologist. Suspected cases
of arthritis were referred for further investigation and were classified according to presence or absence of psoriatic arthritis
according to CASPAR criteria. 
RESULTS: The number of patients with psoriatic arthritis was 47 (35%), 17 of them were new cases. There was no difference
between the groups regarding the type of psoriasis, nail involvement, presence of scalp lesions and psoriatic arthritis. Patients
with psoriatic arthritis had more enthesitis and dactylitis (46.7%) than those without arthritis. 
CONCLUSIONS: Despite the high prevalence of arthritis found, we know that results from epidemiological studies are variable,
which limits their use and interpretation. We conclude that more studies are needed to draw a profile of rheumatic manifes-
tations in our population of psoriasis patients. 
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Resumo: Fundamentos: A artrite psoriásica é uma artrite inflamatória associada à psoríase. Sua prevalência nos pacientes com
psoríase de 7 a 42% mas sua exata prevalência ainda é desconhecida. 
OBJETIVOS: Considerando a escassez de dados nacionais relacionados ao seu diagnóstico em pacientes com psoríase o presen-
te estudo visa descrever o quadro clínico, laboratorial e radiológico da doença nesses pacientes. 
MÉTODOS: Foram avaliados 133 pacientes com diagnóstico de psoríase acompanhados no ambulatório de Psoríase: Esses
pacientes foram submetidos ao preenchimento de fichas com dados sobre sua doença e depois a uma avaliação clínica pelo
dermatologista e reumatologista. Casos suspeitos de artrite foram encaminhados para realização de investigação complemen-
tar e foram classificados quanto à presença ou não de artrite psoriásica segundo critérios de CASPAR. 
RESULTADOS: O número de pacientes com Artrite Psoriásica foi de 47 pacientes (35% ) sendo 17 desses casos novos. Não houve
diferença entre os grupos quanto ao tipo de psoríase, envolvimento ungueal e de couro cabeludo e presença de artrite pso-
riásica. Pacientes com artrite psoriásica apresentaram mais entesites e dactilite (46,7%) do que os sem artrite. 
CONCLUSÕES: Apesar da alta prevalência de artrite encontrada como sabemos que resultados de estudos epidemiológicos são
variáveis levando a limitação em seu uso e interpretação concluímos que mais estudos são necessários para se traçar um per-
fil de manifestações reumatológicas em nossa população de pacientes psoriásicos.
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INTRODUCTION
Rheumatic manifestations are ten to fifteen
times more common in patients with psoriasis than in
the general population. Psoriasis patients even show a
percentage greater than 40% of inflammatory joint
manifestations. 1 Between 5% and 40% of the patients
who suffer from psoriasis will develop psoriatic arth-
ritis, but not every patient with psoriasis will present
with psoriatic arthritis and not any joint manifestation
is psoriatic arthritis. Rheumatoid arthritis, osteoarthri-
tis and joint pain are common in the general popula-
tion and in patients with psoriasis. 2 Nevertheless, it is
recommended that specific enquiry about joint disea-
se should be sought in all patients with psoriasis.
While the prevalence of arthritis in the general
population is estimated at 2-3%, in patients with pso-
riasis it varies from 7 to 42%.
3
Moll and Wright conclu-
ded from a review of epidemiological studies and
scientifically support the concept that psoriatic arthri-
tis is a single entity, with clinical, serological and
radiological characteristics, and provided the earliest
diagnostic criteria for psoriatic arthritis. 4-6 Nowadays
it is generally agreed that while psoriatic arthritis can
be classified among spondyloarthropathies, a family
of disorders sharing common features like inflamma-
tory arthritis, axial involvement, enthesopathy, absen-
ce of rheumatoid factor and association with HLA. 5,6
There is no general agreement in the literature
regarding the prevalence of psoriatic arthritis. The
estimate of prevalence has been difficult because of
the paucity of widely accepted classification or diag-
nostic criteria and the difficulty of most experts in
making a correct diagnosis. 5
There are still some difficulties for the diagno-
sis of psoriatic arthritis, so several classification crite-
ria have been proposed. 7 The CASPAR criteria for clas-
sification are comparable to others but have shown
better sensitivity, facilitating the recruitment of
patients in studies of psoriatic arthritis. 8
The typical clinical features of psoriatic arthritis
include distal joint involvement which occurs in more
than half of patients, but its isolated occurrence is
rare. Oligoarticular involvement is seen and about
half of patients have the spondyloarthropathy form,
which is usually less symptomatic when compared to
ankylosing spondylitis. Half of the patients also have
dactylitis and enthesitis. 4 More recently, three joint
patterns were identified: oligoarticular (£ 4 affected
joints) or polyarticular (≥ 5 joints affected) or perip-
heral pattern and axial pattern with or without asso-
ciated peripheral arthritis. 9
Considering the lack of national data related to
the diagnosis of psoriatic arthritis in patients with pso-
riasis, this study aims to describe the clinical, labora-
torial and radiological features in 133 psoriatic
patients with and without psoriatic arthritis from the




We carried out a cross-sectional study in 133
patients with psoriasis who visited the Outpatient´s
Department of Dermatology at University Hospital of
Brasilia, between November 2009 and December
2010. Convenience sampling was done and our sam-
ple represented 33% of all the patients already enrol-
led in the psoriasis outpatients´ clinic.
The study was approved by the local ethics
committee according to Brazilian Standards for
Research involving Human Subjects and the Helsink
Declaration. We recruited consecutively and included
patients diagnosed with psoriasis, according to clini-
cal criteria by an experienced dermatologist and/or
biopsy. All patients who agreed to participate in the
study signed the informed consent form.
METHODS
Psoriasis’s clinical evaluation was performed by
a dermatologist. The study followed the routine of the
dermatological service with filling of the specific form
where the first skin symptoms, the year of diagnosis,
the form of the disease, nail involvement, scalp invol-
vement, smoking, alcohol consumption, diseases his-
tory, previous treatments and family history of psoria-
sis were recorded. The form was sent to the rheuma-
tologist to collect information for the study.
All patients who agreed to participate in this
study were evaluated by a rheumatologist on the same
day by the protocol for evaluation of joint manifesta-
tions, which included the presence of pain / joint
swelling, dactylitis, enthesitis, neck pain, back pain,
previous diagnosis of psoriatic arthritis or other forms
of arthritis, date of diagnosis and type of joint involve-
ment.
The rheumatologist was the first author of this
study and evaluated all patients according to the
recommendations by GRAPPA (Group for Research
and Assessment of Psoriasis and Psoriatic Arthritis)
and the OMERACT (Outcome Measures in
Rheumatology Clinical Trials). 10 Thus the axial and
peripheral skeletons were clinically evaluated. 11
The suspected cases of psoriatic arthritis were
sent to laboratorial and radiological research. The
diagnosis of psoriatic arthritis was made according to
the CASPAR criteria. 12
Statistical Analysis
We conducted the Kolmogorov-Smirnov test to
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verify the normality of the sample and then used the X
² test, Fischer exact test, Student T and Mann-Whitney
tests. Statistical analyses were undertaken by SPSS ®
version 15.0 (SPSS Inc., Chicago, IL, USA). A p-value
less than 0.05 was considered statistically significant
(p <0.05).
RESULTS
Considering the prevalence of 25% of psoriatic
arthritis in patients with psoriasis the power of the
sample was 60%.
We evaluated 62 men and 71 women diagnosed
with psoriasis. The average age of the sample was 47.5
(± 13.4) years, ranging between 17 and 82 years.
Seven patients reported current alcohol use and 12
were smokers. Eighteen patients had a high blood
pressure (13.5%) and 10 (7.5%) had a diagnosis of dia-
betes mellitus. Only five patients reported a family his-
tory of psoriasis and there was no information in this
regard in 97 of the dermatological reports.
Chart 1 shows the sex distribution by type of
psoriasis. There was no information on the classifica-
tion form of psoriasis from 25 patients.
It is noteworthy that all five patients with the
palmoplantar form were women and two with the
erythrodermic form were male.
Thirty-nine patients (39%) had nail involve-
ment, according to the dermatologist. However, in 50
(38%) patients, the dermatologist did not report whet-
her there were nail changes.
Regarding the presence of scalp involvement,
lesions were reported in 66 (49.6%) patients, but
there was no information on injuries to the scalp in 49
(36.8%) patients.
As for the complaints of the musculoskeletal
system, one hundred and one patients (80.5%) had
joint pain, 91 (68.4%) reported back pain and 67
(50.4%) neck pain. 
The presence of enthesitis was found in 17
(12.8%) patients and the diagnosis of dactylitis was
made in 27 patients (20.3%) at the time of the asses-
sment by the rheumatologist. Regarding the use of
drugs by the patients, it was observed that 30 (22.6%)
patients used anti-inflammatory drugs, 22 (16.5%)
patients used disease-modifying drugs and the use of
biological drugs was reported by 08 (6%) patients.
Previous diagnosis of psoriatic arthritis was
reported by 30 (22.6%) patients with psoriasis. The
disease was present in 35% of men and 25% of
women. Seventeen patients not previously diagnosed
were diagnosed using the CASPAR criteria. Therefore,
the number of patients with psoriatic arthritis in the
study sample was 47 patients, or 35% of the sample.
However, in this study, for the purpose of analyzing
the group with psoriatic arthritis, only patients classi-
fied by the CASPAR criteria, at the moment of the
study, were considered.
Patients with psoriatic arthritis had an average
age of 49 (± 13.2) years, the average age of the popu-
lation without arthritis was 47 (± 14.4) years.
No association was found between the groups with
and without psoriatic arthritis and previous symptoms
of joint, back and neck pain.
There was a great variability in terms of the
time between the first skin symptoms and the diagno-
sis of psoriatic arthritis, which was on average 194
months (16 years) with a median of 174 months (14.5
years), ranging between 08 and 540 months (45).
There was no difference between the groups regar-
ding the type of psoriasis and the diagnosis of psoria-
tic arthritis, chart 2.
It was observed that none of the five patients
with psoriasis guttata had a diagnosis of psoriatic arth-
ritis; however, the two patients with nail psoriasis
were classified as having psoriatic arthritis.
There was no significant association between
lesions on the scalp, nail involvement and the diagno-
sis of psoriatic arthritis. The patients with arthritis
were classified according to the type of involvement
in oligoarthritis (three or 10% of patients), polyarthri-
tis (20 or 67% of patients) and spondyloarthritis
(seven or 23% of patients).
Patients with psoriatic arthritis had more enthe-
sitis than the group without arthritis (Chart 3). There
CHART 1: Classification of psoriasis by sex






Nail psoriasis 1 1
CHART 2: Psoriatic arthritis and the type of psoriasis
Psoriatic Arthritis
Type of psoriasis no yes Total
Vulgar 70 19 89
Guttata 5 0 5
Palmoplantar 4 1 5
Pustular 4 1 5
Erythrodermic 1 1 2
Nail psoriasis 0 2 2
Total 84 24 108
Fischer exact test, * p≤0,05 1
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was no association between the presence of enthesitis
and the type of psoriatic arthritis. However no patient
with oligoarthritis had enthesitis.
The diagnosis of dactylitis was found in 46.7%
of those diagnosed with psoriatic arthritis and in only
12.6% of those without a diagnosis of psoriatic arthri-
tis. There was a weak association between the presen-
ce of dactylitis and psoriatic arthritis.
Table 1 presents the values  of ESR and CRP in
the groups.
The values  of ESR and CRP were not different
between the groups with and without psoriatic arthri-
tis (Mann-Whitney test, p> 0.05). However there was
a tendency to a higher value of CRP in the group with
psoriatic arthritis.
In the group of patients with psoriatic arthritis
nine patients (30%) used anti-inflammatory, twelve
(40%) patients used disease-modifying drugs and
seven (23.3%) patients used biological medications.
Table 2 presents the final diagnosis of rheuma-
tic manifestations. It is noteworthy that only 31% of
the patients with psoriasis from the sample had no
musculoskeletal manifestation.
DISCUSSION
It has been difficult to estimate the prevalence
of psoriatic arthritis as the results of epidemiological
studies have been influenced by several factors: the
diagnostic criteria used, the frequency of psoriasis in
different geographical areas, the average population
age, the case definition and the methodology of the
study. 9
Overall, in studies assessing the prevalence of
psoriatic arthritis in patients with psoriasis seen at
specific clinics it can vary from 6-42%. 2 In studies
involving outpatients such as the one by Altobelli et
al. 13 the prevalence rates reached 26% and in studies
with populations that included both individuals and
the community hospital environment such as the
study by Reich et al. 14 the prevalence reached 20, 6%.
Cross-sectional studies with populations refer-
red to hospital care tend to have a higher prevalence
and this is partly explained by a more intense and sys-
tematic research to define a case and partly because
this group tends to be in the more severe spectrum of
the disease. Our study found a high prevalence of pso-
riatic arthritis (35%) when we considered the patients
who were previously diagnosed and those who met
the CASPAR criteria, at the moment of this study.
Despite the selection bias, on the other hand, we
were careful in trying to make our estimates closer to
reality. The study patients had their diagnosis confir-
med after clinical evaluation by a dermatologist and a
rheumatologist and, as told by Ibrahim et al., such stu-
dies often have estimates closer to reality. 15
Despite the small sample size, statistical signifi-
cance was achieved in important variables. When
compared to the only Brazilian study that evaluates
the prevalence of psoriatic arthritis in psoriasis
patients our study had the largest number of patients
assessed, in addition to being a cross-sectional study.
The study of Aslanian et al. was done by retrospective
analysis of medical records. 16
Most of our patients presented with psoriasis
vulgar, most commonly associated with psoriatic arth-
ritis, but no difference was seen between the groups
regarding the type of psoriasis and the diagnosis of
psoriatic arthritis. The time elapsed between the
onset of symptoms and the diagnosis of psoriatic arth-
ritis was 16 years, which shows that in our environ-
ment the diagnosis of arthritis is usually delayed. 2
According to a review article the majority of
patients (70%) developed psoriasis before the joint
involvement, which was also observed in our study. 9
Because the disease tends to present initially in the
skin, it is important that the dermatologist identifies
the signs of arthritis and then refer the patients to a
rheumatologist. We observed that after the evaluation
by a rheumatologist, 17 new cases of psoriatic arthri-
tis were detected. This was also demonstrated in the
CHART 3: Psoriatic arthritis and enthesitis
Psoriatic Arthritis
no yes Total
Enthesitis No 96 20 116
Yes 07 10 17
Total 103 30 133
TABLE 1: Values of ESR and CRP
Psoriatic Arthritis n Mean Median Standard deviation Standard error
VHS no 45 19,15 15,21 2,27
(mm/1ªh) yes 27 19,89 14,14 2,72
PCR no 33 0,96 1,52 0,27
() Yes 26 1,90 2,24 0,45
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study by TRONTZAS et al. in which rheumatologists
had a correct diagnosis in 87.5% of cases while non
rheumatologists only in 7.7%.17 We know that in our
country the access to a rheumatologist is often diffi-
cult, but recent studies have shown that, fortunately,
rheumatologists and dermatologists, when trained,
can assess both the skin and the joints with a surpri-
sing degree of agreement and accuracy. 18 Thus, we
conclude that the cooperation between these special-
ties for the early detection of psoriatic arthritis is very
important. 19
Given the difficulty in making the diagnosis,
some clinical features should be assessed to predict
psoriatic arthritis. Although nail lesions occur more
frequently in patients with psoriatic arthritis, this was
not observed in our study. In other studies nail lesions
were found in all patients with psoriatic arthritis.
Despite our results, we consider that the presence of
this type of injury suggests the need to investigate
joint disease. 2 In the study by FLORANNE et al. scalp
lesions were strongly associated with psoriatic arthri-
tis. Despite the high frequency of patients with lesions
in the scalp, there was no such correlation in our
study. 20 More than 30% of the patients had no infor-
mation in their protocols on these two variables and
that may have influenced the results.
Dactylitis was associated with the presence of
psoriatic arthritis, which was expected, since it is also
part of the CASPAR criteria. 12
Although regarded as the primary lesion of pso-
riatic arthritis, enthesitis was not frequently found in
our study and this may be because of the difficulty in
the clinical evaluation, since most of the sites of ent-
hesitis are deeply located and further evaluation by
ultrasound or MRI is needed to define its presence. 9
High erythrocyte sedimentation rate and C-
reactive protein were present in 50% of cases but only
the elevated C-reactive protein was correlated with a
higher prevalence of psoriatic arthritis. This can be
explained because the erythrocyte sedimentation rate
is an indirect measure of inflammatory activity and  can
be influenced by a variety of factors including the age
of the patient and the presence of large amounts of
other proteins in the plasma. C-reactive protein is a
better index of inflammatory activity. 21
Many studies have similar results to ours, where
the polyarticular form is the most common, but we
have to stress that the majority of our patients were
not in the early stages of the disease, where the oli-
goarticular forms are more frequently found. 9
On the other hand, the Brazilian study by
Bonfiglioli et al had different results: 62.7% had oli-
goarthritis, and spondyloarthritis was observed in
16.7% and polyarthritis in 15.7% of patients, ie, a
much lower frequency of polyarthritis. 22 It should be
noted, however, that this study was conducted in the
outpatient population referred to rheumatology. This
demonstrates that in Brazil more studies are needed
to confirm and explain the reasons for these divergent
distributions.
Some studies regard having a polyarticular
disease as a factor of poor prognosis and this is the
most commonly found pattern in our population. 23
The use of many medications early in the disease is
also a factor of poor prognosis. Our patients with pso-
riatic arthritis, probably due to the fact that they had
the polyarticular form, which carries the worst prog-
nosis, and also because they had several comorbidities
and illnesses such as diabetes, hypertension, and
mechanical joint diseases, often had a high frequency
of medication use. 23
CONCLUSION
Given the aggressive and debilitating potential
of psoriatic arthritis, the need to draw a profile of the
clinical, radiological and functional capacity of
patients with psoriasis and psoriatic arthritis among
us is increasingly important, since we know that
results from epidemiological studies are variable and
depend on a number of factors leading to limitations
in their use and interpretation. In addition, coopera-
tion between rheumatologists and dermatologists for
the diagnosis and early institution of therapeutic stra-
tegies is important, thus avoiding many complications
commonly associated with this disease. q
TABLE 2: Rheumatic diseases




Myofascial Pain Syndrome 27 (20,3)
Psoriatic Arthritis 30 (22,6)
Indefinite 23 (17,3)
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